Journal of Endocrinological Investigation最新文献_第9页

Sleep quality, stress and thyroid cancer: a case-control study. 睡眠质量、压力和甲状腺癌:一项病例对照研究。

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-06-01 Epub Date: 2022-02-02 DOI: 10.1007/s40618-022-01751-4

S Afrashteh, M Fararouei, M T Parad, A Mirahmadizadeh

{"title":"Sleep quality, stress and thyroid cancer: a case-control study.","authors":"S Afrashteh, M Fararouei, M T Parad, A Mirahmadizadeh","doi":"10.1007/s40618-022-01751-4","DOIUrl":"https://doi.org/10.1007/s40618-022-01751-4","url":null,"abstract":"Background: Stress and sleep disturbance have been found to be associated with numerous adverse health outcomes, including cancer. Our study aimed to measure the association between quality of sleep, short-temperedness, and stress in life with the risk of thyroid cancer.Methods: The present study is conducted on 361 newly diagnosed TC patients and 347 sex-age frequency matched controls. Control and case participants were registered with the same health centers. We used multiple logistic regression to investigate the association between TC risk and the interested factors.Results: Based on the results of the multivariate analysis, stress (ORalways stressful/often calm = 3.07, 95% CI 1.42-6.63) and short-temperedness (ORnervous/calm = 2.00, 95% CI 1.28-3.11) were directly associated with the risk of TC. On the other hand having a quality sleep (ORsometimes/never = 0.36, 95% CI 0.16-0.79) and quality sleep (ORoften/no = 0.45, 95% CI 0.21-0.96, P = 0.041) seems to be a protective factor.Conclusions: Some community-based interventions, e.g., lowering stress levels and improving sleep quality, may help in preventing different types of cancer, including TC. We suggest further evaluation of these important findings in the prevention of TC cancer.","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 6","pages":"1219-1226"},"PeriodicalIF":5.4,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39883772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Depiction of goitre in an Etruscan Genucilia Terracotta plate (late 5th-early 4th BCE). 伊特鲁里亚赤纽西利亚兵马俑板上甲状腺的描绘(公元前5世纪末至公元前4世纪初)。

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-06-01 Epub Date: 2021-08-04 DOI: 10.1007/s40618-021-01657-7

E Varotto, F M Galassi, D Lippi, R Bianucci

引用次数: 1

Human genital tracts microbiota: dysbiosis crucial for infertility. 人类生殖道微生物群:失调对不孕症至关重要。

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-06-01 Epub Date: 2022-02-03 DOI: 10.1007/s40618-022-01752-3

M A Venneri, E Franceschini, F Sciarra, E Rosato, G D'Ettorre, A Lenzi

{"title":"Human genital tracts microbiota: dysbiosis crucial for infertility.","authors":"M A Venneri, E Franceschini, F Sciarra, E Rosato, G D'Ettorre, A Lenzi","doi":"10.1007/s40618-022-01752-3","DOIUrl":"https://doi.org/10.1007/s40618-022-01752-3","url":null,"abstract":"Human body is colonized by trillions of microbes, influenced by several factors, both endogenous, as hormones and circadian regulation, and exogenous as, life-style habits and nutrition. The alteration of such factors can lead to microbial dysbiosis, a phenomenon which, in turn, represents a risk factor in many different pathologies including cancer, diabetes, autoimmune and cardiovascular disease, and infertility. Female microbiota dysbiosis (vaginal, endometrial, placental) and male microbiota dysbiosis (seminal fluid) can influence the fertility, determining a detrimental impact on various conditions, as pre-term birth, neonatal illnesses, and macroscopic sperm parameters impairments. Furthermore, unprotected sexual intercourse creates a bacterial exchange between partners, and, in addition, each partner can influence the microbiota composition of partner's reproductive tracts. This comprehensive overview of the effects of bacterial dysbiosis in both sexes and how partners might influence each other will allow for better personalization of infertility management.","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 6","pages":"1151-1160"},"PeriodicalIF":5.4,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39746442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 18

Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review. 抗甲状腺药物治疗的适当持续时间作为格雷夫斯病复发的预测因子:一项系统的范围回顾

IF 3.9 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-06-01 Epub Date: 2022-01-28 DOI: 10.1007/s40618-021-01730-1

F Azizi, H Abdi, L Mehran, A Amouzegar

{"title":"Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.","authors":"F Azizi, H Abdi, L Mehran, A Amouzegar","doi":"10.1007/s40618-021-01730-1","DOIUrl":"10.1007/s40618-021-01730-1","url":null,"abstract":"Background: Following the conventional 12-18 month antithyroid drug (ATD) treatment in Graves' disease (GD), 50% of patients experience relapse of hyperthyroidism.Objective: The aim of this systematic scoping review was critical appraisal of duration of ATD therapy in the last 80 years.Methods: Articles were identified through the search of PubMed from January 1, 1941 to April 30, 2021. All study types were included. Articles were eligible if they reported data on the length of ATD treatment, particularly thyroid hormones and TSH receptor antibodies (TRAb) concentrations and specifically those with data on the remission and/or relapse rates.Results: We described major progress regarding the duration of ATD therapy and related outcomes at every 20 years. Articles of 1941-1960 were mainly concerned with determination of favorable treatment, minimal effective dose, side effects and rate of remission after < 12-month ATD therapy. Studies with larger number of patients and longer follow-ups appeared in 1961-1980; higher remission rate after 18-24 months versus 6 months of ATD therapy was reported. Articles of 1981-2000 focused on identification of factors associated with high relapse rates after discontinuation of ATD. In 2001-2021, ATD became the first choice of treatment in many countries. However, 12-18 months of ATD therapy was arbitrarily chosen as the appropriate option. According to recent studies, persistent normalization of TRAb occurs after 5 years of methimazole therapy and ATD treatment of > 60 months could offer a 4-year remission rate of 85%.Conclusion: Long-term ATD treatment for more than 60 months is safe and effective, has the highest remission rate and cures most patients with GD; hence, it should be considered as the most appropriate duration for ATD therapy in these patients.","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 6","pages":"1139-1150"},"PeriodicalIF":3.9,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39866115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effects of weight loss on bone turnover, inflammatory cytokines, and adipokines in Chinese overweight and obese adults 减肥对中国超重和肥胖成年人骨转换、炎性细胞因子和脂肪因子的影响

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-05-30 DOI: 10.1007/s40618-022-01815-5

D. Yu, W. Chen, J. Zhang, L. Wei, J. Qin, M. Lei, H. Tang, Y. Wang, S. Xue, J. Dong, Y. Chen, L. Xie, H. Di

引用次数: 3

Noncompliance to iodine supplementation recommendation is a risk factor for iodine insufficiency in Portuguese pregnant women: results from the IoMum cohort 不遵守碘补充建议是葡萄牙孕妇碘不足的一个危险因素:来自IoMum队列的结果

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-05-30 DOI: 10.1007/s40618-022-01813-7

C. Matta Coelho, J. Guimarães, I. Bracchi, N. Xavier Moreira, C. Pinheiro, P. Ferreira, D. Pestana, I. Barreiros Mota, A. Cortez, C. Prucha, C. Martins, E. Pinto, A. Almeida, C. Delerue-Matos, C. Dias, A. Moreira-Rosário, L. F. Ribeiro de Azevedo, V. Cruz Fernandes, C. Ramalho, C. Calhau, A. Brantsæter, J. Costa Leite, E. Keating

引用次数: 4

Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity 对Terry J.Smith博士给编辑的关于替普妥单抗和耳毒性的信的回复

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-05-28 DOI: 10.1007/s40618-022-01829-z

L. Bartalena, C. Marcocci, M. Tanda, M. Marinò

引用次数: 1

Psychological stress, emotions, and quality of life in men and women with congenital adrenal hyperplasia 男性和女性先天性肾上腺增生的心理压力、情绪和生活质量

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-05-25 DOI: 10.1007/s40618-022-01824-4

L. Lašaitė, R. Navardauskaitė, K. Semeniene, R. Verkauskienė

引用次数: 0

Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism 原发性醛固酮增多症单侧肾上腺瘤的肾上腺静脉取样与计算机断层扫描引导下肾上腺切除术的成本-效果比较

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-05-25 DOI: 10.1007/s40618-022-01821-7

S. Arjani, T. Bostonian, V. Prasath, P. Quinn, R. Chokshi

引用次数: 1

First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy Klinefelter ItaliaN组（KING）队列的首次基线数据：意大利成人Klinefelte综合征的临床特征

IF 5.4 2区医学

Journal of Endocrinological Investigation Pub Date : 2022-05-24 DOI: 10.1007/s40618-022-01816-4

D. Pasquali, P. Chiodini, V. Simeon, A. Ferlin, L. Vignozzi, G. Corona, F. Lanfranco, V. Rochira, A. Calogero, M. Bonomi, R. Pivonello, G. Balercia, A. Pizzocaro, V. Giagulli, P. Salacone, A. Aversa, G. Accardo, M. Maggi, A. Lenzi, A. Isidori, C. Foresta, E. Jannini, A. Garolla, D. A. L. G. F. V. A. E. M. R. G. A. V. A. P. A. G. M. Pasquali Ferlin Vignozzi Corona Lanfranco Rochira , D. Pasquali, A. Ferlin, L. Vignozzi, G. Corona, F. Lanfranco, V. Rochira, A. Calogero, M. Bonomi, R. Pivonello, G. Balercia, A. Pizzocaro, V. Giagulli, P. Salacone, A. Aversa, G. Accardo, M. Maggi, A. Lenzi, A. Isidori, C. Foresta, E. Jannini, A. Garolla

引用次数: 1